Literature DB >> 22173911

Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow.

Birgit Assmus1, Masayoshi Iwasaki, Volker Schächinger, Tino Roexe, Masamichi Koyanagi, Kazuma Iekushi, Quanfu Xu, Torsten Tonn, Erhard Seifried, Stefan Liebner, Wolfgang Tilman Kranert, Frank Grünwald, Stefanie Dimmeler, Andreas M Zeiher.   

Abstract

AIMS: We aimed to characterize the influence of acute myocardial infarction (AMI) on the metabolic activity of the bone marrow (BM) and on the composition and functional activity of BM-derived mononuclear cells (BMC). Acute ischaemia or other stressors induce the mobilization of progenitor cells from the BM stem cell niche. The effect of AMI on the numbers and functional activity of cells within the BM is unknown. METHODS AND
RESULTS: In patients of the REPAIR-AMI trial as well as in mice, the number and functionality of BMC was compared with respect to the time interval from AMI. Activation of Wnt signalling was assessed after AMI induction in TOP-GAL transgenic reporter mice, carrying a β-galactosidase gene driven by an LEF/TCF/β-catenin responsive promoter. The metabolic activity of the BM, as determined by F-18-fluorodeoxyglucose-positron emission tomography, was significantly higher in patients with AMI compared with patients with chronic post-ischaemic heart failure. Moreover, the number of haematopoietic CD34(+) (P < 0.05) and CD133(+) (P < 0.05) cells in the BM aspirates was significantly increased in patients within 7 days after AMI. In order to confirm these clinical data, we induced AMI in mice, which time-dependently increased the number of c-kit + Sca-1 + lin- cells and colony-forming units in the BM. Activation of the BM by AMI induced a significant increase in Wnt signalling, which is known to induce proliferation of haematopoietic stem cells, and demonstrated increased levels of the Wnt target Axin-2 in BM-derived cells on Day 7 (P < 0.01 vs. control).
CONCLUSION: Acute myocardial infarction is associated with an increased metabolic activity and increased levels of progenitor cells within days after AMI. These findings document an activation of the stem cell niche within the BM following AMI, which may have important implications for the optimal timing of cell aspirations used for therapeutic application in patients with AMI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173911     DOI: 10.1093/eurheartj/ehr388

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  27 in total

1.  Wnt signalling: a mediator of the heart-bone marrow axis after myocardial injury?

Authors:  Raul A Dulce; Wayne Balkan; Joshua M Hare; Ivonne Hernandez Schulman
Journal:  Eur Heart J       Date:  2011-12-23       Impact factor: 29.983

Review 2.  Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart.

Authors:  Phyllis-Jean Linton; Marilyn L Thoman
Journal:  Immunol Lett       Date:  2014-09-22       Impact factor: 3.685

Review 3.  Cardiac macrophages and their role in ischaemic heart disease.

Authors:  Stefan Frantz; Matthias Nahrendorf
Journal:  Cardiovasc Res       Date:  2014-02-05       Impact factor: 10.787

Review 4.  Hematopoiesis and Cardiovascular Disease.

Authors:  Wolfram C Poller; Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

Review 5.  Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction?

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Eur Heart J       Date:  2015-09-08       Impact factor: 29.983

Review 6.  Monocyte and macrophage heterogeneity in the heart.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2013-06-07       Impact factor: 17.367

7.  Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.

Authors:  Christopher R Cogle; Elizabeth Wise; Amy M Meacham; Claudia Zierold; Jay H Traverse; Timothy D Henry; Emerson C Perin; James T Willerson; Stephen G Ellis; Marjorie Carlson; David X M Zhao; Roberto Bolli; John P Cooke; Saif Anwaruddin; Aruni Bhatnagar; Maria da Graca Cabreira-Hansen; Maria B Grant; Dejian Lai; Lem Moyé; Ray F Ebert; Rachel E Olson; Shelly L Sayre; Ivonne H Schulman; Raphael C Bosse; Edward W Scott; Robert D Simari; Carl J Pepine; Doris A Taylor
Journal:  Circ Res       Date:  2014-08-18       Impact factor: 17.367

Review 8.  Cell-based therapy for prevention and reversal of myocardial remodeling.

Authors:  Vasileios Karantalis; Wayne Balkan; Ivonne H Schulman; Konstantinos E Hatzistergos; Joshua M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

Review 9.  Imaging systemic inflammatory networks in ischemic heart disease.

Authors:  Matthias Nahrendorf; Stefan Frantz; Filip K Swirski; Willem J M Mulder; Gwendalyn Randolph; Georg Ertl; Vasilis Ntziachristos; Jan J Piek; Erik S Stroes; Markus Schwaiger; Douglas L Mann; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2015-04-21       Impact factor: 24.094

Review 10.  Imaging macrophage development and fate in atherosclerosis and myocardial infarction.

Authors:  Filip K Swirski; Matthias Nahrendorf
Journal:  Immunol Cell Biol       Date:  2012-12-04       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.